These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9097847)

  • 1. [Calcitonin and bone aging].
    Reginster JY
    Pathol Biol (Paris); 1997 Jan; 45(1):52-6. PubMed ID: 9097847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin for prevention and treatment of osteoporosis.
    Reginster JY
    Am J Med; 1993 Nov; 95(5A):44S-47S. PubMed ID: 8256795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K; Josse RG
    CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonins and osteoporosis.
    Gennari C; Agnusdei D
    Br J Clin Pract; 1994; 48(4):196-200. PubMed ID: 7917799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with calcitonin in osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Horm Metab Res; 1993 Sep; 25(9):484-5. PubMed ID: 8225202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
    J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis.
    Woo T; Adachi JD
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):469-81. PubMed ID: 11485341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
    Body JJ
    Bone; 2002 May; 30(5 Suppl):75S-79S. PubMed ID: 12008163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the preventive role of estro-progestogens and non-hormonal therapies in postmenopausal osteoporosis].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):677-83. PubMed ID: 8991900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.
    Peichl P; Rintelen B; Kumpan W; Bröll H
    Gynecol Endocrinol; 1999 Feb; 13(1):7-14. PubMed ID: 10368793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcitonin in the prevention and therapy of osteoporosis].
    Ringe JD
    Ther Umsch; 1991 Feb; 48(2):91-9. PubMed ID: 2035172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin therapy in osteoporosis.
    Muñoz-Torres M; Alonso G; Raya MP
    Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of osteoporosis due to ovarian failure.
    Eastell R
    Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current treatment concepts in primary osteoporosis: calcitonin].
    Ringe JD
    Schweiz Med Wochenschr; 1993 Nov; 123(47):2235-40. PubMed ID: 8272794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.